Access cutting-edge breast cancer treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main quest
Sponsor: Sermonix Pharmaceuticals Inc.
Check if you qualify for this breast cancer clinical trial in Scottsdale, AZ
If you're searching for breast cancer treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.